Skip to content
  • Facebook
  • Instagram
  • TikTok
  • Mastodon
  • YouTube
  • X
  • Twitch

Scientific Inquirer

  • Everyday Science.
  • Left Brain/Right Brain.
  • Sports.
  • Features.
  • About.
  • Contact.

cancer

  • Types of bacteria vary widely in tumors of people with early vs. late-onset colorectal cancer
    May 31, 2023

    Types of bacteria vary widely in tumors of people with early vs. late-onset colorectal cancer

    bricemarsters
  • ASCO: Targeted therapy for early breast cancer, progress treating recurrent glioma, PSMA PET scan advances and more
    May 25, 2023

    ASCO: Targeted therapy for early breast cancer, progress treating recurrent glioma, PSMA PET scan advances and more

    bricemarsters
  • Delivering on the promise of personalized breast cancer therapy
    May 24, 2023

    Delivering on the promise of personalized breast cancer therapy

    bricemarsters
  • New probe aids novel findings on cell functions
    May 17, 2023

    New probe aids novel findings on cell functions

    bricemarsters
  • AI predicts future pancreatic cancer
    May 17, 2023

    AI predicts future pancreatic cancer

    bricemarsters
  • Revised Mammogram Guidelines: Health Experts Recommend Screenings Begin at Age 40.
    May 9, 2023

    Revised Mammogram Guidelines: Health Experts Recommend Screenings Begin at Age 40.

    scientificinquirer
  • Breast cancer tumors disrupt the immune system remotely favoring their own growth
    May 9, 2023

    Breast cancer tumors disrupt the immune system remotely favoring their own growth

    bricemarsters
  • Red flags indicate risk for early-onset colorectal cancer
    May 8, 2023

    Red flags indicate risk for early-onset colorectal cancer

    bricemarsters
  • Imaging live drug response and resistant ‘pockets’ in pancreatic cancer
    May 4, 2023

    Imaging live drug response and resistant ‘pockets’ in pancreatic cancer

    bricemarsters
  • “Mirror-image” molecules pave new path for cancer drug discovery
    May 2, 2023

    “Mirror-image” molecules pave new path for cancer drug discovery

    bricemarsters
Previous Page
1 … 20 21 22 23 24 … 53
Next Page

Categories

Asia.

North America.

Europe.

Africa.

South America.

Australia.

Science For All, Not Just The Few.

Subscribe to our newsletters. We’ll keep you in the loop.

  • Facebook
  • Instagram
  • TikTok
  • Mastodon
  • YouTube
  • X
  • Twitch
  • Everyday Science.
  • Left Brain/Right Brain.
  • Sports.
  • Features.
  • About.
  • Contact.

Designed with WordPress

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}

Loading Comments...